Both in Pharmaceuticals
NanoViricides vs Grace Therapeutics
Over the past year NNVC returned −5.2% and GRCE returned −37.0%; their daily moves had a correlation of 0.08.
NNVC −5.2% GRCE −37.0%Growth of $1, one year, split-adjusted
| Metric | NNVC | GRCE |
|---|---|---|
| Price | $1.45 | $2.01 |
| Market cap | $37.0M | $42.3M |
| Today | −0.68% | +7.49% |
| 1 month | +11.5% | −4.7% |
| 6 months | +18.9% | −4.3% |
| Year to date | +28.3% | −41.9% |
| 1 year | −9.9% | −36.2% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $2.8M | $13.8M |
| Dividend yield | — | — |
| Volatility (60d) | 89.0% | 41.0% |
| Short % of float | 4.6% | 11.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).